Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022
Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from…
News
Hillstream BioPharma to Present at BioNJ’s 12th Annual BioPartnering Virtual Conference Held on May 9- 13, 2022
Developed in partnership with J.P. Morgan and Johnson & Johnson Innovation, the Conference will bring…
Enlivex Announces Issuance of Two U.S. Patents Covering Methods of Treating Sepsis with Allocetra
Nes-Ziona, Israel, May 05, 2022 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
Coherus BioSciences Appoints Charlie Newton to Board of Directors
– Biotechnology Chief Financial Officer and highly regarded former healthcare investment banker brings decades of…
Palisade Bio and Newsoara Receive NMPA Clearance to Commence Phase 3 Clinical Trial in China Evaluating LB1148 to Accelerate the Return of Bowel Function Following Abdominal Surgery
NMPA clearance expands global Phase 3 clinical development program; Company recently announced clearance from U.S….
Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium for Cosmetic Advances & Laser Education
Live Demonstration of New RhodoLED® XL to be Featured WOBURN, Mass., May 05, 2022 (GLOBE…
Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors
Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharma NEW YORK, May 05, 2022…
ABVC BioPharma Announces Streamlined Vitargus® Manufacturing Process
New Process Improves Quality and Lowers Cost Fremont, CA, May 05, 2022 (GLOBE NEWSWIRE) —…
Wave Life Sciences to Webcast Conference Call of First Quarter 2022 Financial Results on May 12, 2022
CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
SCYNEXIS to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12
JERSEY CITY, N.J., May 05, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
Acer Therapeutics to Participate in H.C. Wainwright Global Investment Conference
NEWTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
Tarsus Presents New Findings from Two Studies Demonstrating the Impact of Demodex Blepharitis at the ARVO 2022 Annual Meeting
IRVINE, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission…
Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures
TiHawk7 combines ultra-low 7mm insertion profile with strong titanium/PEEK adhesion while still allowing for radiographic…
Synthetic Biologics Announces Formation of Scientific Advisory Board to Advance Oncology Pipeline
Scientific Advisory Board of leading experts in oncolytic adenoviruses and gene therapies strengthens transformative clinical…
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage…
Revolo Biotherapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium
NEW ORLEANS and LONDON, May 05, 2022 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…
Neoleukin Therapeutics to Present at Upcoming Investor Conferences
SEATTLE, May 05, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Fulcrum Therapeutics to Participate at the Upcoming BofA Securities 2022 Healthcare Conference
CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical…
NKGen Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting
SANTA ANA, Calif., May 05, 2022 (GLOBE NEWSWIRE) — NKGen Biotech Inc., a biotechnology company…
Belite Bio Presented Interim Results of LBS-008 Phase 1b/2 Study in Adolescent STGD1 at ARVO Annual Meeting 2022
LBS-008 (aka Tinlarebant) showed an acceptable safety profile in adolescent Stargardt disease (STGD1) subjects A…